Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy

NCT00986973 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Phenylketonuria

Interventions

DRUG: Sapropterin

Sponsor

Children's Hospital of Philadelphia